FDA approval for Sercon’s ABCA2

FDA approval for Sercon’s ABCA2

Jan 9, 2024

FDA approval for Sercon’s ABCA2 We’ve just received our renewal of FDA approval for Sercon’s ABCA2 automated breath 13CO2 analyser. MD Mark O’Connor is proud of the achievement: “The ABCA2 is the only FDA approved, high performance IRMS instrument with large sample...
ABCA Used for Pancreatic Cancer Diagnosis Research

ABCA Used for Pancreatic Cancer Diagnosis Research

Nov 9, 2023

Service Engineer James Hanson has just been to Southampton General Hospital and performed a successful dual turbo upgrade and full service on a Sercon ABCA system being used by Dr Paul Afolabi in the Mass Spectrometry Lab. Dr Paul Afolabi will use the Sercon ABCA...
Data bulletin: Sercon ABCA Maintenance and Decontamination

Data bulletin: Sercon ABCA Maintenance and Decontamination

Apr 27, 2020

Any breath sample has the potential to include contaminants such as bacteria and viruses Simple precautions can be taken to prevent the build up and spread of these contaminants. Read more in our bulletin >   Data Bulletin – Sercon ABCA Maintenance and...
The ABCA2’s role in early detection of liver damage

The ABCA2’s role in early detection of liver damage

Dec 21, 2016

One of the scientists using Sercon’s ABCA2 at Southampton General Hospital is hopeful the technique he has developed will help in the prevention of liver damage and type 2 diabetes in a world where obesity is causing ever more health problems. Dr Paul Afolabi,...